Impact of CD4+ blood cell count and HIV viral load on treatment response with direct acting antivirals in HIV and HCV coinfected patients: insights from the German Hepatitis C-Registry.
Jenny BischoffStefan MaussChristiane CordesThomas LutzStefan ScholtenMarkus CornbergMichael P MannsAxel BaumgartenJürgen K RockstrohPublished in: HIV clinical trials (2019)
We found high SVR12 rates in HIV/HCV coinfected patients and no significant difference was observed due to the patients CD4+ cell count, HIV viral load, portal hypertension or liver cirrhosis.
Keyphrases
- hepatitis c virus
- end stage renal disease
- antiretroviral therapy
- human immunodeficiency virus
- hiv positive
- hiv infected
- ejection fraction
- newly diagnosed
- chronic kidney disease
- hiv testing
- prognostic factors
- hiv aids
- men who have sex with men
- bone marrow
- patient reported outcomes
- mesenchymal stem cells
- peripheral blood
- cell therapy
- south africa